The Paget Foundation : For Paget's disease of bone and related disorders
โ Scribed by Charlene Waldman
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 27 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
In 1978, The Paget Foundation was founded as an organization devoted to providing information concerning Paget's disease of bone to patients and medical professionals. Over the years, the Foundation expanded its programs to include other disorders of abnormal bone resorption, including primary hyperparathyroidism, fibrous dysplasia, osteopetrosis, and the complications of certain cancers to the skeleton.
The Third North American Symposium on Skeletal Complications of Malignancy was the fourth Paget Foundation program for medical professionals on this important subject.
๐ SIMILAR VOLUMES
The goals of treatment of Paget's disease must be readdressed in the context of the availability of potent bsphosphonate compounds, including pamidronate and, more recently, alendronate and risedronate. These agents differ from the traditional mainstays of therapy, salmon calcitonin and etidmnate, i
## Abstract Little is known about how Paget's disease of bone affects quality of life. To better understand the relative impact of factors on quality of life, we mailed a brief survey to 2000 people randomly selected from the Paget's Foundation mailing list. The sample was geographically stratified
To assess the use of quantitative bone scanning (QBS) in the monitoring of patients with intravenous pamidronate-treated symptomatic monostotic Paget's disease of bone in whom biochemical markers of bone turnover are relatively normal. Methods. QBS was performed in 9 patients and the results were e